한글목차

경구용 단백질 및 펩티드 시장 규모는 최근 비약적으로 확대하고 있습니다. 2025년 15억 6,000만 달러에서 2026년에는 19억 1,000만 달러에 이르고, CAGR 22.5%의 성장이 전망되고 있습니다. 지금까지의 성장 요인으로는 단백질-펩타이드의 경구 생체 이용률의 한계, 주사제에 대한 의존도, 당뇨병 및 소화기 질환의 유병률 증가, 펩타이드 치료제의 연구 진전, 초기 단계의 경구용 펩타이드 의약품에 대한 규제 승인 등을 들 수 있습니다.

경구용 단백질 및 펩티드 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 42억 6,000만 달러에 이르고, CAGR은 22.2%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 새로운 경구용 단백질 전달 기술 개발, 만성질환 관리 프로그램 확대, 개인 맞춤형 치료 및 병용요법 채택 증가, 대사 및 내분비 질환에 대한 의료비 지출 증가, 디지털 복약 관리 및 모니터링 도구의 통합 등이 있습니다. 예측 기간 동안 주요 동향으로는 경구용 인슐린 및 기타 치료용 펩타이드의 도입 증가, 개인 맞춤형 의료 및 표적 경구용 단백질 치료의 성장, 소화기 질환 치료에 대한 관심 증가, 당뇨병 및 대사성 질환을 위한 경구용 단백질 제제의 확대, 장시간 지속형 및 복합 경구용 단백질 제품의 발전 등을 들 수 있습니다. 발전 등을 꼽을 수 있습니다.

지속적으로 확대되고 있는 바이오의약품 산업은 향후 몇 년 동안 경구용 단백질 및 펩타이드 시장의 성장을 견인할 것으로 예측됩니다. 바이오의약품 산업은 생물 유래 의약품의 개발, 제조, 상업화에 특화된 넓은 의미의 제약 분야의 한 분야입니다. 이 산업의 확대는 생명공학의 발전, 개인 맞춤형 의료에 대한 수요 증가, 만성질환의 유병률 증가, 연구개발에 대한 투자 확대에 의해 뒷받침되고 있습니다. 바이오의약품 분야에서 경구용 단백질-펩타이드는 비침습적 치료제 전달의 가능성을 제공하여 환자의 복약 순응도를 높이고 주사 치료의 필요성을 줄일 수 있습니다. 또한, 특정 질환에 대한 표적 치료를 가능하게 하는 동시에 소화기 내 안정성과 흡수성 향상을 가져옵니다. 예를 들어, 영국 정부 통계 기관인 '생명과학 및 헬스케어 기술 부문'에 따르면, 2023/2024년 영국 생명과학 산업은 7,320개 기업에서 6,170개의 사업체가 활동하며 35만 9,600명을 고용하고 1,469억 파운드(1,696억 9,000만 달러)의 매출을 기록할 것으로 예측됩니다.의 매출을 창출했습니다. 그 결과, 바이오의약품 산업의 확대가 경구용 단백질-펩타이드 시장의 성장에 기여하고 있습니다.

경구용 단백질 및 펩타이드 시장에서 활동하는 주요 기업들은 경구용 제형에서 펩타이드의 안정성, 투과성, 생체 이용률을 향상시키는 첨단 제제 기술 개발에 주력하고 있습니다. 이러한 혁신은 효소에 의한 분해 및 소화관 내 흡수 제한과 같은 오랜 문제를 해결하기 위한 것입니다. 예를 들어, 2025년 8월 독일에 본사를 둔 바이오메디컬 연구소인 바이오메드 엑스(BioMed X)는 덴마크 제약사 노보노디스크(Novo Nordisk)와 새로운 제휴를 맺고 차세대 경구용 펩타이드 전달 기술 개발에 박차를 가하고 있습니다. 이 파트너십은 안전하고 효과적이며 환자 친화적인 경구용 펩타이드 치료제를 개발하기 위한 새로운 분자적 접근법과 전달 메커니즘을 탐구하는 데 초점을 맞추었습니다. 바이오메드 엑스의 초기 단계 연구 강점과 노보노디스크의 펩타이드 의약품에 대한 전문성을 결합하여 혁신적인 경구용 약물 전달 솔루션을 개발하고, 대사성 질환 및 만성 질환에 대한 펩타이드 의약품의 치료 적용 범위를 확대하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Oral proteins and peptides refer to therapeutic proteins and peptide-based drugs that are administered by mouth, commonly in the form of tablets, capsules, or other ingestible preparations. These biologically active compounds are developed to manage a range of medical conditions by utilizing their targeted actions within the body.

The primary drug types of oral proteins and peptides include linaclotide, calcitonin, insulin, plecanatide, and octreotide. Their biological targets include guanylate cyclase-C (GC-C), the insulin receptor, oxalate, and others, while the mechanisms of action involve receptor stimulation, substrate degradation, and additional pathways. These therapies are applied across various indications such as gastrointestinal disorders, bone diseases, neurological disorders, diabetes, metabolic disorders, hormonal disorders, and cancer.

Tariffs have impacted the oral proteins and peptides market by increasing costs for imported biologics, excipients, and specialized delivery technologies. Segments like oral insulin formulations and long-acting peptide therapies are most affected, particularly in North America, Europe, and Asia-Pacific regions that depend on imports. This has led to higher production costs and potential delays in product availability. On the positive side, tariffs have encouraged domestic production, innovation in oral delivery systems, and diversification of local manufacturing capabilities.

The oral proteins and peptides market research report is one of a series of new reports from The Business Research Company that provides oral proteins and peptides market statistics, including oral proteins and peptides industry global market size, regional shares, competitors with a oral proteins and peptides market share, detailed oral proteins and peptides market segments, market trends and opportunities, and any further data you may need to thrive in the oral proteins and peptides industry. This oral proteins and peptides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral proteins and peptides market size has grown exponentially in recent years. It will grow from $1.56 billion in 2025 to $1.91 billion in 2026 at a compound annual growth rate (CAGR) of 22.5%. The growth in the historic period can be attributed to limited oral bioavailability of proteins and peptides, reliance on injectable formulations, growing prevalence of diabetes and gastrointestinal disorders, increasing research in peptide therapeutics, regulatory approvals for early oral peptide drugs.

The oral proteins and peptides market size is expected to see exponential growth in the next few years. It will grow to $4.26 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to development of novel delivery technologies for oral proteins, expansion of chronic disease management programs, rising adoption of personalized and combination therapies, increasing healthcare expenditure on metabolic and hormonal disorders, integration of digital adherence and monitoring tools. Major trends in the forecast period include rising adoption of oral insulin and other therapeutic peptides, growth in personalized medicine and targeted oral protein therapies, increasing focus on gastrointestinal disorder treatments, expansion of oral protein formulations for diabetes and metabolic disorders, advancement in long-acting and combination oral protein products.

The expanding biopharmaceutical industry is anticipated to drive the growth of the oral proteins and peptides market in the coming years. The biopharmaceutical industry is a segment of the broader pharmaceutical sector that concentrates on the development, production, and commercialization of drugs derived from biological sources. The expansion of this industry is supported by advances in biotechnology, rising demand for personalized medicine, the increasing prevalence of chronic diseases, and higher investments in research and development. In biopharmaceutical applications, oral proteins and peptides provide the potential for non-invasive therapeutic delivery, improving patient compliance and minimizing the need for injectable treatments. They also enable targeted treatment of specific diseases while offering improved stability and absorption within the digestive system. For example, in October 2025, according to the Bioscience and Health Technology Sector, a UK-based government statistics source, during 2023/2024 there were 6,170 businesses operating in the UK life sciences industry across 7,320 companies. These organizations employed 359,600 people and generated £146.9 ($169.69) billion in turnover. As a result, the expansion of the biopharmaceutical industry is contributing to the growth of the oral proteins and peptides market.

Major companies operating in the oral proteins and peptides market are concentrating on the development of advanced formulation technologies to improve peptide stability, permeability, and bioavailability in oral dosage forms. These innovations are designed to address long-standing challenges such as enzymatic degradation and limited absorption in the gastrointestinal tract. For instance, in August 2025, BioMed X, a Germany-based biomedical research institute, entered into a new collaboration with Novo Nordisk, a Denmark-based pharmaceutical company, to accelerate the development of next-generation oral peptide delivery technologies. This partnership focuses on exploring new molecular approaches and delivery mechanisms to enable safe, effective, and patient-friendly oral peptide therapies. By combining BioMed X's early-stage research strengths with Novo Nordisk's expertise in peptide-based medicines, the collaboration aims to advance innovative oral drug delivery solutions and broaden the therapeutic applications of peptide medicines across metabolic and chronic conditions.

In April 2023, Chiesi Farmaceutici S.p.a., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed amount. This acquisition allows Chiesi to leverage Amryt's unique product portfolio and promising development pipeline, strengthening its commitment to rare diseases and enhancing its biopharmaceutical capabilities. Amryt Pharma Plc is a UK-based company specializing in oral proteins and peptides.

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

North America was the largest region in the oral proteins and peptides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral proteins and peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral proteins and peptides market consists of sales of protein supplements, peptide-based drugs, and therapeutic formulations designed for oral administration. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Proteins And Peptides Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oral proteins and peptides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral proteins and peptides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oral proteins and peptides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Linaclotide; Calcitonin; Insulin; Plecanatide; Octreotide
• 2) By Biological Target: Guanylate Cyclase-C (GC-C); Insulin Receptor; Other Biological Targets
• 3) By Mechanism Of Action: Receptor Stimulation; Substrate Degradation; Other Mechanisms Of Action
• 4) By Application: Gastrointestinal Disorders; Bone Disease; Neurological Disorders; Diabetes; Metabolic Disorders; Hormonal Disorder; Cancer
• Subsegments:
• 1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS); Indications For Chronic Idiopathic Constipation (CIC)
• 2) By Calcitonin: Calcitonin-Salmon; Synthetic Calcitonin; Calcitonin for Osteoporosis Treatment
• 3) By Insulin: Long-Acting Insulin; Combination Insulin Products; Oral Insulin Formulations
• 4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC); Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
• 5) By Octreotide: Long-Acting Octreotide Formulations; Short-Acting Octreotide Formulations; Indications For Acromegaly And Neuroendocrine Tumors
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca PLC; Eli Lilly and Company; Novo Nordisk A/S; Ipsen S.A.; Biocon Limited; Xeris Pharmaceuticals Inc.; Adocia S.A.; Zealand Pharma A/S; Diabetology Ltd.; Oramed Pharmaceuticals Inc.; Palatin Technologies Inc.; Entera Bio Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Oral Proteins And Peptides Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Oral Proteins And Peptides Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Oral Proteins And Peptides Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Oral Proteins And Peptides Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Oral Insulin And Other Therapeutic Peptides
  • 4.2.2 Growth In Personalized Medicine And Targeted Oral Protein Therapies
  • 4.2.3 Increasing Focus On Gastrointestinal Disorder Treatments
  • 4.2.4 Expansion Of Oral Protein Formulations For Diabetes And Metabolic Disorders
  • 4.2.5 Advancement In Long-Acting And Combination Oral Protein Products

5. Oral Proteins And Peptides Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Pharmacies
• 5.4 Diabetes Care Centers
• 5.5 Research & Academic Institutions

6. Oral Proteins And Peptides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oral Proteins And Peptides Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Oral Proteins And Peptides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Oral Proteins And Peptides Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Oral Proteins And Peptides Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Oral Proteins And Peptides Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oral Proteins And Peptides Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oral Proteins And Peptides Market Segmentation

• 9.1. Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
• 9.2. Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Guanylate Cyclase-C (GC-C), Insulin Receptor, Other Biological Targets
• 9.3. Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
• 9.4. Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
• 9.5. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
• 9.6. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
• 9.7. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
• 9.8. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
• 9.9. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

10. Oral Proteins And Peptides Market Regional And Country Analysis

• 10.1. Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oral Proteins And Peptides Market

• 11.1. Asia-Pacific Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oral Proteins And Peptides Market

• 12.1. China Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oral Proteins And Peptides Market

• 13.1. India Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oral Proteins And Peptides Market

• 14.1. Japan Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oral Proteins And Peptides Market

• 15.1. Australia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oral Proteins And Peptides Market

• 16.1. Indonesia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oral Proteins And Peptides Market

• 17.1. South Korea Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oral Proteins And Peptides Market

• 18.1. Taiwan Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oral Proteins And Peptides Market

• 19.1. South East Asia Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oral Proteins And Peptides Market

• 20.1. Western Europe Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oral Proteins And Peptides Market

• 21.1. UK Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oral Proteins And Peptides Market

• 22.1. Germany Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oral Proteins And Peptides Market

• 23.1. France Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oral Proteins And Peptides Market

• 24.1. Italy Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oral Proteins And Peptides Market

• 25.1. Spain Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oral Proteins And Peptides Market

• 26.1. Eastern Europe Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oral Proteins And Peptides Market

• 27.1. Russia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oral Proteins And Peptides Market

• 28.1. North America Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oral Proteins And Peptides Market

• 29.1. USA Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oral Proteins And Peptides Market

• 30.1. Canada Oral Proteins And Peptides Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oral Proteins And Peptides Market

• 31.1. South America Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oral Proteins And Peptides Market

• 32.1. Brazil Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oral Proteins And Peptides Market

• 33.1. Middle East Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oral Proteins And Peptides Market

• 34.1. Africa Oral Proteins And Peptides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oral Proteins And Peptides Market Regulatory and Investment Landscape

36. Oral Proteins And Peptides Market Competitive Landscape And Company Profiles

• 36.1. Oral Proteins And Peptides Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Oral Proteins And Peptides Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Oral Proteins And Peptides Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Oral Proteins And Peptides Market Other Major And Innovative Companies

• Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

38. Global Oral Proteins And Peptides Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market

40. Oral Proteins And Peptides Market High Potential Countries, Segments and Strategies

• 40.1 Oral Proteins And Peptides Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Oral Proteins And Peptides Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Oral Proteins And Peptides Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer